Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.

Auboyer L, Monzo C, Wallon D, Rovelet-Lecrux A, Gabelle A, Gazagne I, Cacheux V, Lehmann S, Crozet C.

Stem Cell Res. 2019 Jan;34:101381. doi: 10.1016/j.scr.2018.101381. Epub 2019 Jan 3.

2.

Cell-based therapy against prion diseases.

Relaño-Ginés A, Lehmann S, Crozet C.

Curr Opin Pharmacol. 2018 Nov 22;44:8-14. doi: 10.1016/j.coph.2018.11.001. [Epub ahead of print] Review.

PMID:
30472550
3.

Lithium as a disease-modifying agent for prion diseases.

Relaño-Ginés A, Lehmann S, Brillaud E, Belondrade M, Casanova D, Hamela C, Vincent C, Poupeau S, Sarniguet J, Alvarez T, Arnaud JD, Maurel JC, Crozet C.

Transl Psychiatry. 2018 Aug 22;8(1):163. doi: 10.1038/s41398-018-0209-4.

4.

[Therapeutic Patient Education training for nursing students: A case study.]

Kaci C, Crozet C, Gillard-Berthod C, Van Rooj G, Marchand C.

Rech Soins Infirm. 2018 Jun;(133):70-84. doi: 10.3917/rsi.133.0070. French.

PMID:
30066510
5.

Children with chronic disease and extracurricular activities: training needs

Desserprix A, Marchand C, Crozet C.

Sante Publique. 2016 Oct 19;28(4):439-449. French.

PMID:
28155748
6.

Haemophilia: how sentinel patients have developed a warning semiotics

Verheye JC, Robin L, Crozet C, D'Ivernois JF.

Rev Prat. 2015 Nov;65(9):1218-1220. French.

PMID:
30512517
7.

What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization.

Lefèvre T, d'Ivernois JF, De Andrade V, Crozet C, Lombrail P, Gagnayre R.

Rev Epidemiol Sante Publique. 2014 Oct;62(5):305-14. doi: 10.1016/j.respe.2014.09.002. Epub 2014 Oct 25. Review.

8.

Prion diseases and adult neurogenesis: how do prions counteract the brain's endogenous repair machinery?

Relaño-Ginés A, Lehmann S, Crozet C.

Prion. 2014;8(3):240-6. Epub 2014 May 15.

9.

Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

Lehmann S, Relano-Gines A, Resina S, Brillaud E, Casanova D, Vincent C, Hamela C, Poupeau S, Laffont M, Gabelle A, Delaby C, Belondrade M, Arnaud JD, Alvarez MT, Maurel JC, Maurel P, Crozet C.

PLoS One. 2014 Feb 14;9(2):e88797. doi: 10.1371/journal.pone.0088797. eCollection 2014.

10.

High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.

van der Laan S, Tsanov N, Crozet C, Maiorano D.

Mol Cell. 2013 Nov 7;52(3):366-79. doi: 10.1016/j.molcel.2013.10.003.

11.

Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases.

Relaño-Ginès A, Gabelle A, Hamela C, Belondrade M, Casanova D, Mourton-Gilles C, Lehmann S, Crozet C.

PLoS Pathog. 2013;9(8):e1003485. doi: 10.1371/journal.ppat.1003485. Epub 2013 Aug 1.

12.

[Learning strategies and computer lectures].

Lafont P, Marchand C, Crozet C.

Rech Soins Infirm. 2012 Dec;(111):81-100. French.

PMID:
23409548
13.

Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner.

Relaño-Ginés A, Lehmann S, Bencsik A, Herva ME, Torres JM, Crozet CA.

J Infect Dis. 2011 Oct 1;204(7):1038-45. doi: 10.1093/infdis/jir484.

PMID:
21881119
14.

Characteristics and development of therapeutic patient education in rheumatoid arthritis: analysis of the 2003-2008 literature.

Albano MG, Giraudet-Le Quintrec JS, Crozet C, d'Ivernois JF.

Joint Bone Spine. 2010 Oct;77(5):405-10. doi: 10.1016/j.jbspin.2010.01.010. Epub 2010 Apr 8. Review.

PMID:
20381401
15.

Gene and cell therapy for prion diseases.

Relaño-Ginés A, Gabelle A, Lehmann S, Milhavet O, Crozet C.

Infect Disord Drug Targets. 2009 Feb;9(1):58-68. Review.

PMID:
19200016
16.

Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature.

Roche S, Delorme B, Oostendorp RA, Barbet R, Caton D, Noel D, Boumediene K, Papadaki HA, Cousin B, Crozet C, Milhavet O, Casteilla L, Hatzfeld J, Jorgensen C, Charbord P, Lehmann S.

Proteomics. 2009 Jan;9(2):223-32. doi: 10.1002/pmic.200800035.

PMID:
19142956
17.

Effective gene therapy in a mouse model of prion diseases.

Toupet K, Compan V, Crozet C, Mourton-Gilles C, Mestre-Francés N, Ibos F, Corbeau P, Verdier JM, Perrier V.

PLoS One. 2008 Jul 23;3(7):e2773. doi: 10.1371/journal.pone.0002773.

18.

Analysis of the 2004-2007 literature on therapeutic patient education in diabetes: results and trends.

Albano MG, Crozet C, d'Ivernois JF.

Acta Diabetol. 2008 Dec;45(4):211-9. doi: 10.1007/s00592-008-0044-9. Epub 2008 Jul 17.

PMID:
18633570
19.

Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage.

Béranger F, Crozet C, Goldsborough A, Lehmann S.

Biochem Biophys Res Commun. 2008 Sep 12;374(1):44-8. doi: 10.1016/j.bbrc.2008.06.094. Epub 2008 Jul 3.

PMID:
18602368
20.

Cellular pathogenesis in prion diseases.

Crozet C, Beranger F, Lehmann S.

Vet Res. 2008 Jul-Aug;39(4):44. doi: 10.1051/vetres:2008021. Epub 2008 Apr 17. Review.

Supplemental Content

Loading ...
Support Center